Targeting MMP-12 may help to reduce or prevent the pathological EMT and tissue remodeling observed in CRSwNP, thereby providing a novel approach to treating this chronic inflammatory condition [13, 21]. This evidence concerns the gene MMP12 and chronic rhinosinusitis with nasal polyps.